• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Lymphoma, Large-Cell, Immunoblastic

Lymphoma, Large-Cell, Immunoblastic - 10 Studies Found

Completed : Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
:
  • Lymphoma, Non-Hodgkin
  • HIV Infections

: 1999-11-02
:
  • Drug: Mitoxantrone hydrochloride
  • Drug: Eto

Completed : Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (BMT CTN 0401)
:
  • Lymphoma, B-Cell
  • Lymphoma, Large-Cell, Immunoblastic
  • : 2006-05-22
    :
    • Drug: Autologous transplantation using rituxan/BEAM

Completed : Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
:
  • AIDS-related Diffuse Large Cell Lymphoma
  • AIDS-related Immunoblastic La
    : 2002-11-12
    :
    • Biological: rituximab Given IV

Completed : Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
:
  • AIDS-related Non-Hodgkin Lymphoma
  • AIDS-related Plasmablastic Lymphoma<
    : 2013-09-09
    :
    • Drug: busulfan Given IV

Completed : Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
: Lymphoma
: 1999-11-01
:
  • Biological: bleomycin sulfate
  • Drug: CHOP r

Not yet recruiting : Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
:
  • Adult Burkitt Lymphoma
  • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between D
    : 2015-05-26
    :
    • Drug: Cyclophosphamide Given I

Active, not recruiting : Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    : 2004-08-04
    :
    • Drug: fludarabine phosphate Gi

Terminated : Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma
:
  • Adult Non-Hodgkin Lymphoma
  • Adult Grade III Lymphomatoid Granulomatosis
  • Drug: lenalidomide Given orall

Completed : Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma : 2009-04-29
    :
    • Drug: R-(-)-gossypol acetic acid

Completed : RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma : 2010-07-07
    :
    • Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097

Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.